OG'IR COVID-19 BILAN KASALLANGAN BEMORLARDA SEREBRAL VENOZ TROMBOZLAR

##article.authors##

  • Azimov Anvar Tairovich

##article.subject##:

serebral venoz trombozi, COVID-19, antikoagulyantlar

##article.abstract##

COVID-19da serebral venoz trombozi nisbatan keng tarqalgan asorat ekanligi isbotlangan. Serebral venoz trombozi mavjudligi og'ir COVID-19 bilan og'rigan bemorlarda yomon prognoz uchun mustaqil xavf omilidir. Maqolada COVID-19 bilan kasallangan bemorlarda serebral venoz trombozining epidemiologiyasi bo'yicha adabiyotlar ko'rib chiqilgan. Maqolada COVID-19 bilan kasallangan bemorlarda serebral venoz trombozi antikoagulyant profilaktikasi bo'yicha muallifning tadqiqotlari keltirilgan. Shuningdek, 48 yoshli bemorda insult xavfi omillari bo'lmaganda serebral venoz trombozi va miya venoz infarktining klinik holati keltirilgan.

Библиографические ссылки

Временные рекомендации по ведению пациентов, инфицированных COVID-19, (5-версия). МЗ РУз и национальной палаты здравоохранения РУз, Акилов Х. и др., июнь 2020 года.

Azimov AT, Rakhimbayeva GS (2021). Aspects of the prevention of cerebrovascular complications in COVID-19: a literature review. JOURNAL OF NEUROLOGY AND NEUROSURGERY RESEARCH. 2021; 4: с. 30-35. https://doi.org/10.5281/zenodo.5807828

Азимов АТ, Рахимбаева ГС, Азимов ФЗ. Антикоагулянтная терапия в профилактике инсульта у пациентов с тяжелой формой COVID-19. Неврология, нейропсихиатрия, психосоматика. 2021;13(5):20–25. DOI: 10.14412/2074-2711-2021-5-20-25

Baldini T, Asioli GM, Romoli M, Carvalho Dias M, Schulte EC, Hauer L, Aguiar De Sousa D, Sellner J, Zini A. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021 Oct;28(10):3478-3490. doi: 10.1111/ene.14727. Epub 2021 Feb 2. PMID: 33426733; PMCID: PMC8014715.

Hameed S, Wasay M, Soomro B, A, Mansour O, Abd-allah F, Tu T, Farhat R, Shahbaz N, Hashim H, Alamgir W, Iqbal A, Khan M: Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study. Cerebrovasc Dis Extra 2021;11:55-60. doi: 10.1159/000516641.

Mehta JL, Calcaterra G, Bassareo PP. COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past. ClinCardiol. 2020;43(12):1362-1367. doi:10.1002/clc.23460

Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani-Haghighi A, Ciccone A, Gomez CR, Gurkas E, Hsu CY, Jani V, et al.. Management of acute ischemic stroke in patients with COVID-19 infection: report of an international panel.Int J Stroke. 2020; 15:540–554. doi:10.1177/1747493020923234

Khodjieva D.T., Safarov K.K. A Study of Neuropsychological Symptomatology and Its Clinical Features in Patients with COVID-19. American Journal of Medicine and Medical Sciences 2021, 11(2): 126-129

Abootalebi S, Aertker BM, Andalibi MS, Asdaghi N. et alCall to Action: SARS-CoV-2 and CerebrovAscularDisordErs (CASCADE). //J Stroke Cerebrovasc Dis. 2020 Sep;29(9):104938.

Avula A., Nalleballe K., Narula N. et al. COVID-19 presenting as stroke. //Brain BehavImmun 2020. DOI: 10.1016/j.bbi.2020.04.077.

Benussi A, Pilotto A, Premi E, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy //Neurology. 2020;10.1212/WNL.0000000000009848.

Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19 //J Neurol Neurosurg Psychiatry. 2020;jnnp-2020-323586.

Bikdeli B., Madhavan M.V., Jimenez D. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J AmCollCardiol 2020. DOI: 10.1016/j.jacc.2020.04.031.

Aghayari Sheikh Neshin S, Shahjouei S, Koza E, et al. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front CardiovascMed. 2021;8:649922. Published 2021 Mar 29. doi:10.3389/fcvm.2021.649922

Ling Mao, Mengdie Wang, Shanghai Chen et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv, 2020.02.22.200265 0010.1101/2020.02.22.20026500 (accessed on 2020-02-28).

Khaydarova D.K., Khodjieva D.T., Khaydarov N.K. Magnetic Resonance Imaging of Cerebral Hemorrhagic Stroke. International Journal of Psychosocial Rehabilitation, Vol. 24, 2020. 434-438

Salzberger B., Buder F., Lampl B., et al. Epidemiology of SARS-CoV-2 [published online ahead of print, 2020 Oct 8] // Infection. 2020; 1-7.

http://www.proteinatlas.org Электронный ресурс, дата обращения 15.10.2020 г.

Li Y. C., Bai W. Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients // J Med Virol. 2020, Feb 27. [Epub ahead of print].

Satarker S., Nampoothiri M. Involvement of the nervous system in COVID-19: The bell should toll in the brain [published online ahead of print, 2020 Oct 6] // Life Sci. 2020; 262: 118568.

Moriguchi T., Harii N., Goto J., et al. A first case of meningitis/ encephalitis associated with SARS-Coronavirus-2 // Int J Infect Dis. 2020; 94: 55-58. DOI: 10.1016/j.ijid.2020.03.062.

Khodjieva D.T., Khaydarov N.K., Kazakov B.Sh., Khaydarova D.K. Clinical and neurological factors in the formation of an individual predisposition to COVID-associated ischemic stroke. European Journal of Molecular & Clinical Medicine - 2020.

Рахимбаева Гульнора Саттаровна, Шодиев Улуғбек Дониёр ўғли. Постковид цeрeбро-астeник синдром: диагностик ёндашувларни оптималлаштириш, долзарб жихатлари // Журнал неврологии и нейрохирургических исследований №2.2021. 6-10 бет.

Туйчиев Л.Н., Рахимбаева Г.С., Газиева Ш.Р., Атаниязов М.К. Новая коронавирусная ин¬фекция и постковидные неврологиче¬ские последствия заболевания // Вестник ТМА № 2, 2021. 45-50 стр.

Атаниязов Махсуджан Камаладдинович, Рахимбаева Гульнора Саттаровна, Газиева Шохида Рустамовна. Характерные особенности инсульта при covid-19 // Журнал неврологии и нейрохирургических исследований №2.2021.14-17 стр.

Загрузки

##submissions.published##

2022-02-26